EDSA (Edesa Biotech) Institutional Ownership: 30.16% (As of Jul. 13, 2026)


EDSA Edesa Biotech Inc EDSA
31 GF Score
Price $7.01
! 2 Warning Signs
View Full Analysis

What is Edesa Biotech Institutional Ownership?

Edesa Biotech EDSA -1.82% 31 Institutional Ownership is 30.16% as of Jul. 13, 2026. GuruFocus rates EDSA with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Edesa Biotech's institutional ownership is 30.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Edesa Biotech's Insider Ownership is 16.69%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Edesa Biotech's Float Percentage Of Total Shares Outstanding is 92.74%.

Edesa Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Edesa Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edesa Biotech Institutional Ownership Chart

Edesa Biotech Historical Data

The historical data trend for Edesa Biotech can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.76 0.76 0.76 0.67 0.67 0.67 1.82 1.83 1.92 1.66
EDSA
31GF Score
Edesa Biotech Inc EDSA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edesa Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 30.16% mean?
Edesa Biotech (EDSA) has a Institutional Ownership of 30.16% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Edesa Biotech and its competitors.
Is Edesa Biotech's Institutional Ownership too high?
Edesa Biotech's current Institutional Ownership is 30.16%. Overall, Edesa Biotech has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Edesa Biotech's Institutional Ownership compare to ACET and HRTX?
Edesa Biotech's Institutional Ownership of 30.16% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Edesa Biotech and its competitors. Edesa Biotech's current Institutional Ownership is 30.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edesa Biotech stock overvalued right now?
Edesa Biotech (EDSA) has a current Institutional Ownership of 30.16%. The current Institutional Ownership is 30.16%. Edesa Biotech's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Edesa Biotech (EDSA), the current Institutional Ownership is 30.16% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edesa Biotech Business Description

Address 100 Spy Court, Markham, ON, CAN, L3R 5H6
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
31GF Score

Get the complete analysis for EDSA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.01
Price